仅饮水禁食对妇科恶性肿瘤化疗实施的影响
随机对照试验纳入接受至少6个计划化疗周期的妇科恶性肿瘤患者,比较每个周期前24小时及后24小时仅饮水禁食与非禁食患者。分析120个化疗周期,禁食组体重减轻与意外住院相似,化疗减量或延迟更少,生活质量评分无显著差异但禁食组随时间改善达到最小临床重要差异。
要点
- 48小时仅饮水禁食耐受良好,未增加体重减轻、住院或化疗减量/延迟。
- 禁食组治疗调整更少,生活质量评分随治疗改善达到最小临床重要差异。
- 两组平均生活质量评分无显著差异。
核心结论
- 48小时禁食耐受良好,不增加体重减轻、住院或化疗减量/延迟,禁食组治疗调整更少且生活质量评分随治疗改善。
研究设计与样本
- 随机对照试验,纳入接受至少6个计划化疗周期的妇科恶性肿瘤女性,比较每个化疗周期前24小时及后24小时仅饮水禁食与非禁食患者。
- 分析包括120个化疗周期的数据,11例卵巢癌、8例子宫癌、1例宫颈癌,90%接受紫杉烷和铂类双药治疗。
主要发现
- 禁食组与非禁食组体重减轻和意外住院相似。
- 禁食组化疗减量或延迟更少。
- 两组平均生活质量评分无显著差异,但禁食组生活质量评分随治疗改善达到最小临床重要差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: As a protective response, during starvation organisms withdraw energy from growth and reproduction to focus on cellular maintenance. Cancer cells cannot undergo this differential response which has been theorized as an adjunct to improve both the effect of chemotherapy treatment and reduce treatment side effects. We sought to investigate the feasibility and effect of short-term fasting in patients receiving chemotherapy for gynecologic malignancy. METHODS: A randomized control trial was conducted of women with gynecologic malignancies receiving at least 6 planned chemotherapy cycles. Fasting patients maintaining a water-only fast for 24 h before and 24 h following each chemotherapy cycle were compared to nonfasting patients. Treatment related side effects and quality of life (QOL) was assessed using NCCN-FACT FOSI-18 questionnaire. RESULTS: Analysis included data from 120 cycles of chemotherapy. The majority of patients had stage 3 and 4 malignancy requiring multi-agent chemotherapy. Eleven patients had ovarian, 8 had uterine, and 1 had cervical cancer. Ninety percent received taxane and platinum-based doublet therapy. Weight loss and unanticipated hospitalizations were similar between treatment groups. Fewer dose reductions or delays were seen in the fasting group. There was no significant difference in mean QOL scores, but fasting group QOL scores improved over the course of treatment to a level that reached the minimal clinically important difference. CONCLUSION: A 48-h fast is well tolerated without increasing weight loss, hospital admissions, or chemotherapy dose reduction/delays. Fasting resulted in fewer treatment modifications and improved quality of life scores over the course of treatment.
引用
- Riedinger CJ, Kimball KJ, Kilgore LC, et al. Water only fasting and its effect on chemotherapy administration in gynecologic malignancies. Gynecol Oncol. 2020. PMID: 32958269. doi:10.1016/j.ygyno.2020.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。